TY  - JOUR
A1  - Schmid, Christoph
A1  - Atzler, M.
A1  - Rank, A.
A1  - Inngjerdingen, M.
A1  - Rabe, A.
A1  - Deen, D.
A1  - Wang, R.
A1  - Eiz-Vesper, B.
A1  - Schmetzer, H.
T1  - Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells
T2  - European Journal of Cancer
KW  - Cancer Research
KW  - Oncology
Y1  - 2018
UR  - https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98414
SN  - 0959-8049
VL  - 92
IS  - Supplement 1
SP  - S15
PB  - Elsevier BV
CY  - Amsterdam
ER  -